Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,487 GBX | +0.17% | -0.98% | +17.60% |
05:56am | AstraZeneca's Type-2 Diabetes Drug Wins Pediatric Approval in US | MT |
06-12 | AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S. | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.60% | 248B | |
+48.79% | 781B | |
+41.66% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+0.25% | 221B | |
+11.66% | 217B | |
+4.53% | 162B | |
-3.92% | 157B | |
-0.51% | 121B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca to Develop $1.5 Billion Singapore Manufacturing Facility